ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Corbevax COVID-19 vaccine gets DCGI's nod for children aged 5-12

Corbevax COVID-19 vaccine gets DCGI's nod for children aged 5-12

Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) granted emergency use...


      
      DCGI grants emergency use authorisation to ZycovD COVID vaccine

DCGI grants emergency use authorisation to ZycovD COVID vaccine

Ahmedabad (Gujarat) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted...


      
      Covaxin cleared for 6-12 age group

Covaxin cleared for 6-12 age group

New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use...


      
      Bharat Biotech asked to give more data on COVID vaccine Covaxin

Bharat Biotech asked to give more data on COVID vaccine Covaxin

New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...


      
      SEC's recommends Corbevax COVID-19 vaccines for kids aged 5-11

SEC's recommends Corbevax COVID-19 vaccines for kids aged 5-11

New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...


      
      DCGI to discuss to use COVID-19 vaccines for 5-12 age group

DCGI to discuss to use COVID-19 vaccines for 5-12 age group

New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller...


      
      DCGI claims India on course to become global drugs hub

DCGI claims India on course to become global drugs hub

New Delhi [India], April 14 (ANI): Claiming that India is on course to become a 'global hub for medicines', Dr VG...

      
      Glenmark Specialty S.A. receives approval for conducting trial

Glenmark Specialty S.A. receives approval for conducting trial

Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven,...

      
      Bharat Biotech to rectify issues raised by WHO on Covaxin soon

Bharat Biotech to rectify issues raised by WHO on Covaxin soon

New Delhi [India], April 4 (ANI): Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues...


      
      Phase 2,3 trial data of India's first mRNA COVID vaccine...

Phase 2,3 trial data of India's first mRNA COVID vaccine...

New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III...

      
      DCGI grants emergency use authorisation to SII's COVID-19...

DCGI grants emergency use authorisation to SII's COVID-19...

New Delhi [India], March 9 (ANI): The Drugs Controller General of India (DCGI) has granted Emergency Use...


      
      Zydus Lifesciences gets DCGI approval for Oxemia drug

Zydus Lifesciences gets DCGI approval for Oxemia drug

Ahmedabad (Gujarat) [India], March 7 (ANI): Zydus Lifesciences on Monday said it has received approval from the Drug...
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.